IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS

被引:1
|
作者
Gossec, L. [1 ,2 ]
Coates, L. [3 ]
Orbai, A. M. [4 ]
De Wit, M. [5 ]
Pelligra, C. [6 ]
Lambert, J. [7 ]
Ciaravino, V. [7 ]
Ink, B. [8 ]
Taieb, V. [7 ]
Gladman, D. D. [9 ]
机构
[1] Sorbonne Univ, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Paris, France
[3] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England
[4] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA
[5] Stichting Tools, Amsterdam, Netherlands
[6] Evidera, Medellin, Colombia
[7] UCB Pharma, Colombes, France
[8] UCB Pharma, Slough, Berks, England
[9] Univ Toronto, Schroeder Arthrit Inst, Krembil Res Inst, Toronto Western Hosp, Toronto, ON, Canada
关键词
Psoriatic arthritis; Clinical trials; Patient reported outcomes; OUTCOME MEASURE; VALIDATION;
D O I
10.1136/annrheumdis-2023-eular.1980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0590-HP
引用
收藏
页码:565 / 566
页数:2
相关论文
共 50 条
  • [11] Defining Cutoffs Corresponding to Low Levels of Disease Activity in Psoriatic Arthritis, Using the Patient-Reported Psoriatic Arthritis Impact of Disease Questionnaire (PsAID12). an Analysis of 436 Patients
    Gorlier, Clemence
    Puyraimond-Zemmour, Deborah
    Orbai, Ana-Maria
    Coates, Laura C.
    Kiltz, Uta
    Leung, Ying Ying
    Palominos, Penelope
    Canete, Juan D.
    Scrivo, Rossana
    Balanescu, Andra Rodica
    Dernis, Emmanuelle
    Talli, Sandra
    Ruyssen-Witrand, Adeline
    Soubrier, Martin
    Aydin, Sibel Zehra
    Eder, Lihi
    Gaydukova, Inna
    Lubrano, Ennio
    Richette, Pascal
    Husni, M. Elaine
    de Wit, Maarten
    Smolen, Josef S.
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [12] ASSESSMENT OF PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE FOR EVALUATIONS OF 6-YEARS TREAT-TO-TARGET STRATEGY OUTCOMES
    Tremaskina, P.
    Loginova, E.
    Vorobyova, L.
    Korotaeva, T.
    Chamurlieva, M.
    Glukhova, S.
    Lila, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1587 - 1588
  • [13] MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS IS ASSOCIATED WITH LOW IMPACT OF DISEASE ON PSAID12 QUESTIONAIRE
    Mosquera Martinez, J. A.
    Garcia-Porrua, C.
    Fernandez-Dominguez, L.
    Guerra-Vazquez, J. L.
    Pinto-Tasende, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1711 - 1711
  • [14] EFFECT OF DEUCRAVACITINIB ON THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PsAID) QUESTIONNAIRES 12 AND 9: ANALYSIS OF A PHASE 2 STUDY OF ACTIVE PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L. C.
    Ogdie, A.
    Mease, P. J.
    Lehman, T.
    Nowak, M.
    Wei, L.
    Ye, J.
    Choi, J.
    Zhuo, J.
    Becker, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1316 - 1317
  • [15] Impact of Psoriatic Arthritis from the Patient's Perspective in the Context of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire: An Online Global Survey
    Coates, Laura C.
    Orbai, Ana-Maria
    Azevedo, Valderilio F.
    Cappelleri, Joseph C.
    Moser, Jade
    Lippe, Ralph
    Lim, Irwin
    Eder, Lihi
    Richette, Pascal
    Weng, Meng-Yu
    Queiro, Ruben
    Fallon, Lara
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [16] IMPACT OF PSORIATIC ARTHRITIS FROM THE PATIENT'S PERSPECTIVE IN THE CONTEXT OF THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID) QUESTIONNAIRE: AN ONLINE GLOBAL SURVEY
    Coates, Laura
    Orbai, Ana-Maria
    Azevedo, Valderilio
    Cappelleri, Joseph C.
    Moser, Jade
    Lippe, Ralph
    Eder, Lihi
    Richette, Pascal
    Weng, Meng-Yu
    Queiro Silva, Ruben
    Fallon, Lara
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S9 - S10
  • [17] PSORIATIC ARTHRITIS IMPACT OF DISEASE QUESTIONNAIRE SCORES ARE CORRELATED WITH DISEASE ACTIVITY, AS MEASURED BY CDAPSA, IN PATIENTS WITH PSORIATIC ARTHRITIS
    Orbai, Ana-Maria
    Krueger, Klaus
    Behrens, Frank
    Kiltz, Uta
    Guerette, Benoit
    Mellars, Lillian
    Brunori, Michele
    Wollenhaupt, Jurgen
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1856 - 1856
  • [18] THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE IS VALID IN ARABIC AND STRONGLY LINKED TO DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ARAB-SPEAKING COUNTRIES: AN ARLAR INITIATIVE
    Ziade, N.
    Abbas, N.
    Hmamouchi, I.
    Kibbi, L.
    Maroof, A.
    Zorkany, B.
    Al-Ani, N. A.
    Ridha, A.
    Ihsan, N.
    Gorial, F. Isho
    Al Chama, N.
    Haouichet, C.
    Alnaimat, F.
    Hannawi, S.
    Atawina, S.
    Halabi, H.
    Mashaleh, M.
    Aljazwi, L.
    Abogamal, A.
    Ayoub, L.
    Bouajina, E.
    Bahiri, R.
    Saad, S.
    Sabkar, M.
    Aouad, K.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1138 - 1139
  • [19] DAPSA REMISSION/LOW DISEASE ACTIVITY IS ASSOCIATED WITH LOW PSAID12 IN PSORIATIC ARTHRITIS
    Garcia-Porrua, C.
    Fernandez-Dominguez, L.
    Guerra-Vazquez, J. L.
    Mosquera Martinez, J. A.
    Pinto-Tasende, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1679 - 1680
  • [20] The Use of Disease Activity Thresholds for the Psoriatic Arthritis Impact of Disease Questionnaire to Assess Patient Perceptions of Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast in a Phase 4 Trial
    Gossec, Laure
    Coates, Laura
    Gladman, Dafna
    Ogdie, Alexis
    Nash, Peter
    Poddubnyy, Denis
    Kavanaugh, Arthur
    Armstrong, April
    Selmi, Carlo
    Silva, Ruben Queiro
    Deignan, Cynthia
    Wang, Rebecca
    Reddy, Jyotsna
    Brunori, Michele
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2976 - 2978